Orange Book product · Brand (NDA)
BAQSIMI
GLUCAGON
At a glance
Jul 24, 2019
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 24, 2019
7 yr ago
Today
Exclusivity ends · NPP
New patient population exclusivity (3 years)
Mar 17, 2028
in 1 yr 9 mo
Patent 10213487 expires
Listed drug product patent expiration.
Feb 16, 2036
in 9 yr 10 mo
Patent 12370241 expires
Listed drug product patent expiration.
Feb 16, 2036
in 9 yr 10 mo
Patent 10765602 expires
Listed drug product patent expiration.
Sep 23, 2039
in 13 yr 5 mo
Pharmaceutical detail
Active ingredient
GLUCAGON
Strength
3MG
Dosage form
POWDER
Route
NASAL
TE code
Not listed
Application
NDA 210134
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Marketing exclusivity (1)
- NPPNew patient population exclusivity (3 years)
Mar 17, 2028
in 1 yr 9 mo
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10213487 | Feb 16, 2036 | in 9 yr 10 mo | ProductU-2604 |
| 12370241 | Feb 16, 2036 | in 9 yr 10 mo | ProductU-2604 |
| 10765602 | Sep 23, 2039 | in 13 yr 5 mo | Product |
